Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

Completed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy, such as temozolomide, vincristine, and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of irinotecan when given together with temozolomide and vincristine in treating young patients with refractory solid tumors.

Key facts

Study ID
NCT00138216
Run by
Children's Oncology Group
People needed
42
Starts
2005-10-01
Expected to finish
2011-01-01
Last updated by the study team
2023-10-02

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.